Do patients with active RA have differences in disease activity and perceptions if anti-TNF naïve versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial

BACKGROUND: The chance of a good response in RA is attenuated in previous anti-TNF users who start new anti-TNF therapy compared to biologic naïve patients. In active RA, those with previous anti-TNF exposure compared to anti-TNF naïve may have different baseline disease activity and patient percept...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Janet, Thorne, J. Carter, Haraoui, Boulos Paul, Psaradellis, Eliofotisti, Sampalis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Public Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560709/
https://www.ncbi.nlm.nih.gov/pubmed/22847212
http://dx.doi.org/10.12659/MSM.883250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560709/
https://www.ncbi.nlm.nih.gov/pubmed/22847212
http://dx.doi.org/10.12659/MSM.883250

Ejemplares similares